Cyclopentyl-pyrimidine based analogues as novel and potent IGF-1R inhibitor

Add time:07/12/2019    Source:sciencedirect.com

A series of novel 2-amino-4-pyrazolecyclopentylpyrimidines have been prepared and evaluated as IGF-1R tyrosin kinase inhibitors. The in vitro activity was found to depend strongly on the substitution pattern in the 2- amino ring, 4-pyrazolo moieties and size of fused saturated ring with the central pyrimidine core. A stepwise optimization by combination of active fragments led to discovery of compound 6f and 6k, two structures with IGF-1R IC50 of 20 nM and 10 nM, respectively. 6f was further profiled for its anti cancer activity across various cell lines and pharmacokinetic studies in Sprague Dawley rats.

We also recommend Trading Suppliers and Manufacturers of 6-chloro-N4-[2-(dimethylamino)ethyl]pyrimidine-4,5-diamine (cas 88442-83-5). Pls Click Website Link as below: cas 88442-83-5 suppliers

Prev:Design and synthesis of quinazoline-3,4-(4H)-diamine endowed with thiazoline moiety as new class for DPP-4 and DPPH inhibitor
Next:Supramolecular self-assembly and thermodynamic properties of 5-aryl-1-(1,1-dimethylethyl)-1H-pyrazoles in the crystalline state)